High Density Mapping in Brugada Syndrome
- Conditions
- Brugada Syndrome
- Registration Number
- NCT06567639
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria:<br><br> 1. high density epicardial EAM performed with the multipolar mapping catheter Advisor™<br> HD-Grid Mapping Catheter, (Abbott Labs, Abbott Park, IL, USA) in association with<br> the EnSite Precision™ Cardiac Mapping System, (Abbott Labs, Abbott Park, IL, USA);<br><br> 2. epicardial EAM performed before and after ajmaline infusion at standard protocol (1<br> mg/kg in 5 minutes);<br><br> 3. ECGI activation map performed before and after ajmaline and concomitant with<br> invasive EAM acquisition.<br><br>Exclusion Criteria:<br><br> 1. Spontaneous BrS type I pattern ECG during EAM acquisition. Patients were included if<br> they had a history of spontaneous BrS type I;<br><br> 2. other diagnosis different from BrS syndrome or overlap syndrome diagnosis by means<br> of genetic analysis, transthoracic echocardiography, computed tomography (CT) or<br> magnetic resonance imaging;<br><br> 3. use of a different mapping catheter or mapping system;<br><br> 4. history of previous BrS substrate ablation.
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HD-grid electrograms
- Secondary Outcome Measures
Name Time Method